A Comparison Between the Aysis® Cs2 (General Electrics) Ventilator in EtControl® Mode and the Perseus® A 500 (Dräger) in VaporView® Mode on Maniability and Consumption of Desflurane
ConsoHalo
1 other identifier
observational
60
1 country
1
Brief Summary
The Aysis® Cs2 ventilator offers an automated control of end-tidal inhalation anesthetic concentration, the EtControl® mode. A low Fresh Gas Flow (FGF) (0.5L/min) is kept during the maintenance of the anesthesia, decreasing the expensive consumption of halogenated agents. The Perseus® A 500 offers a VaporView® mode that gives the evolution of inspired (Fi) and end-tidal (Fe) fractions of halogenated agents for 20 minutes based on the delivered fraction (Fd). FGF remains adjusted manually by the practitioner. This mode also makes it possible to maintain a low FGF (0.5 L/min), provided the halogen Fd is set to maintain a steady Fe curve. The goal of this work was to compare the maniability of the intraoperative administered concentrations and the consumption of Desflurane between these 2 modalities of administration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 15, 2015
CompletedFirst Posted
Study publicly available on registry
April 28, 2015
CompletedApril 28, 2015
April 1, 2015
3 months
April 15, 2015
April 27, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Consumption of Desflurane between these 2 modalities of administration.
Des consumption was measured by micrometric weighing of the vaporizer before and after general anesthesia and a milliliter per min consumption was calculated
Time of general anesthesia (1h minimum up to 12h)
Secondary Outcomes (3)
Comparison of inspired (Fi) and end-tidal (Fe) fractions of halogenated evolution
Time of general anesthesia (1h minimum up to 12h)
Anesthesia depth monitoring by BIS
Time of general anesthesia (1h up to 12h)
Hemodynamic stability
Time of general anesthesia (1h minimum up to 12h)
Study Arms (2)
Perseus
Use of Perseus® A 500 with VaporView® mode that gives the evolution of inspired (Fi) and end-tidal (Fe) fractions of halogenated agents for 20 minutes based on the delivered fraction (Fd). FGF remains adjusted manually by the practitioner. This mode also makes it possible to maintain a low FGF (0.5 L/min)
Aysis
Use of Aysis® Cs2 ventilator with automated control of end-tidal inhalation anesthetic concentration, EtControl® mode.
Eligibility Criteria
ASA 1/2 adult patients undergoing a general anesthesia of more than one hour.
You may qualify if:
- patients undergoing a general anesthesia for intra abdominal surgery during more than one hour
- ASA 1or 2
You may not qualify if:
- contraindication to halogenated agent
- thoracic surgery
- no french speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Saint-Antoine
Paris, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
April 15, 2015
First Posted
April 28, 2015
Study Start
January 1, 2015
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
April 28, 2015
Record last verified: 2015-04